SiRNA in tandem expression and uses thereof in treating chronic lymphocytic leukemia
US10273481B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 2015 |
| Grant date | Apr 30, 2019 |
| Priority date | — |
| Expiry date | Jun 17, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2330/51
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Provided is an siRNA in tandem expression and uses thereof in treating chronic lymphocytic leukemia, and particularly, provided are a method of a tandem expression for siRNA of BTK, and an siRNA in tandem expression and uses thereof in treating chronic lymphocytic leukemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.